Demis Hassabis, CEO of DeepMind, has stated that artificial intelligence has the potential to cure all diseases within the next decade. He attributes this possibility to AI’s ability to transform drug development and biological research. According to Hassabis, AI systems could reduce the time required to develop new drugs from several years to just a few weeks.

DeepMind has already contributed to this field through AlphaFold, an AI system that has predicted the structures of more than 200 million proteins. This advancement provides researchers with critical information about protein folding, which can significantly speed up the identification of disease targets and the design of therapeutic interventions.

Despite this progress, experts and observers have emphasized the complexity of human diseases and the necessity of rigorous clinical trials and regulatory approval before treatments can be considered safe and effective. They caution against overestimating AI’s short-term capabilities, highlighting that biomedical breakthroughs require more than computational predictions.

View the video beginning at 2:55